Dr Danielle Anderson
Honorary (Senior Fellow)
Department of Microbiology and Immunology
93 Scholarly works
10 Projects
HIGHLIGHTS
2026
Journal article
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
DOI: 10.1038/s41541-025-01355-y2026
Journal article
An emerging human eye disease is associated with aquatic virus zoonotic infection
DOI: 10.1038/s41564-026-02266-x2026
Journal article
Integrating Prevention and Response at the Crossroads of Henipavirus Preparedness, Hendra@30 Conference, 2024
DOI: 10.3201/eid3201.2509792025
Journal article
Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus
DOI: 10.1038/s43856-025-00863-12023
Research grants (ARC, NHMRC, MRFF)
RNA Powered Antiviral Antibodies
2022
Research grants (other domestic)
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
2022
Research Grant
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13
RECENT SCHOLARLY WORKS
2025
Journal article
Epidemiologic and Genomic Characterization of an Outbreak of Rift Valley Fever Among Humans and Dairy Cattle in Northern Tanzania
DOI: 10.1093/infdis/jiae5622025
Journal article
Seroprevalence and risk factors for Crimean-Congo hemorrhagic fever virus exposure among febrile patients in northern Tanzania
DOI: 10.1111/tmi.140822025
Book Chapter
Severe Acute Respiratory Syndrome (SARS)
DOI: 10.1016/B978-0-323-54841-0.00011-12024
Journal article
Pan-viral Antibody Repertoire of Aqueous Humor in Cytomegalovirus Uveitis
DOI: 10.1016/j.ajo.2024.05.0042024
Book Chapter
Identification of Host Factors of Paramyxoviruses by siRNA Genome-Wide Screens
DOI: 10.1007/978-1-0716-3870-5_82023
Journal article
Author Correction: Engineering antiviral immune-like systems for autonomous virus detection and inhibition in mice (Nature Communications, (2022), 13, 1, (7629), 10.1038/s41467-022-35425-9)
DOI: 10.1038/s41467-023-39774-x
RECENT PROJECTS
2025
Research grants (other domestic)
Developing CRISPR Cas13 Antiviral Therapeutics for Respiratory Pathogens of Pandemic Potential
2022
Internal Research Grant
mRNA-based Antiviral Therapeutics for SARS-CoV-2 Using Cas13